nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 ›...

8

Transcript of nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 ›...

Page 1: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 2: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 3: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 4: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 5: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 6: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 7: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve
Page 8: nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve

An Invitation to Market Design Files/18-019_b138aaa9-55f6-484e-a7c5...: d47,c78,d44,d82,d02,d51,d71,d61,d62,d63 ∗

An Invitation to Market Design Files/18-019_b138aaa9-55f6-484e-a7c5...: d47,c78,d44,d82,d02,d51,d71,d61,d62,d63 ∗

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

JEREMÍAS JEREMIAS92339049-7208-4fd1-b5e1-d44… · JEREMÍAS JEREMIAS Dirigido por/Directed by NICOS BEATTY ESPINOSA Productora/Production Company: MAGNO ENTERTAINMENT, S.L. Robi,

JEREMÍAS JEREMIAS92339049-7208-4fd1-b5e1-d44… · JEREMÍAS JEREMIAS Dirigido por/Directed by NICOS BEATTY ESPINOSA Productora/Production Company: MAGNO ENTERTAINMENT, S.L. Robi,

Hw00 Figueroa

Hw00 Figueroa

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

D44. cre 2018 graficos.docx enTitle Microsoft Word - D44. cre_2018_graficos.docx_en Author X000975 Created Date 12/30/2019 1:13:50 PM

D44. cre 2018 graficos.docx enTitle Microsoft Word - D44. cre_2018_graficos.docx_en Author X000975 Created Date 12/30/2019 1:13:50 PM

D44 Newsletter Oct 2015

D44 Newsletter Oct 2015

Troubleshooting Guide for HPE ProLiant Gen10 serverst-mash.ru/upload/iblock/d44/d44a84e7404d36258cfb5f9d09f7ef47.pdf · OS boot issues flowchart.....51 Fault indications flowchart

Troubleshooting Guide for HPE ProLiant Gen10 serverst-mash.ru/upload/iblock/d44/d44a84e7404d36258cfb5f9d09f7ef47.pdf · OS boot issues flowchart.....51 Fault indications flowchart

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

THREAD MILLS - Niagara Cutter GT14-115... · THREAD MILLING DISCOUNT CODE D44 • Helical flutes for internal and external threading EDP DESCRIPTION

THREAD MILLS - Niagara Cutter GT14-115... · THREAD MILLING DISCOUNT CODE D44 • Helical flutes for internal and external threading EDP DESCRIPTION

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Short Listed Candidates - Kendriya Vidyala No. 1 Gwaliorkv1gwalior.org/english/images/wscst.pdfSURESH KUMAR D44 JAGJIVAN NAGAR GANDHI ROAD MORAR, GWALIOR kioskbtr@gmail.com Government

Short Listed Candidates - Kendriya Vidyala No. 1 Gwaliorkv1gwalior.org/english/images/wscst.pdfSURESH KUMAR D44 JAGJIVAN NAGAR GANDHI ROAD MORAR, GWALIOR [email protected] Government

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1 … › hepstudy › presentations › ...Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 A1444040 Trial

Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1 … › hepstudy › presentations › ...Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 A1444040 Trial

D44 Toastmasters - The Messenger

D44 Toastmasters - The Messenger

Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced

Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced